Zheng Zhiyuan, Lin Donghong, Chen Qiaoqian, Zheng Bin, Liang Mingqiang, Chen Chun, Zheng Wei
Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, People's Republic of China.
Medical Technology and Engineering College of Fujian Medical University, Fuzhou, Fujian, 350004, People's Republic of China.
Cancer Manag Res. 2021 Mar 12;13:2359-2370. doi: 10.2147/CMAR.S296266. eCollection 2021.
We retrospectively analyzed the prognostic value of the albumin-to-fibrinogen ratio (AFR)-neutrophil-to-lymphocyte ratio (NLR) score, comprising preoperative AFR and NLR, in esophageal squamous cell carcinoma (ESCC) patients after radical resection.
Overall, 215 patients were included. The optimal cutoff value was determined using the receiver operating characteristic (ROC) curve. Based on a low AFR (<12.06) and high NLR (≥1.78), the AFR-NLR score was classified as 2 (both hematological abnormalities present), 1 (one abnormality present), or 0 (both abnormalities absent). Kaplan-Meier curves, Cox regression, and predicted nomogram were used to evaluate the prognostic value of the score.
The prognostic value of the AFR-NLR score was better than that of AFR or NLR alone ( <0.05). Multivariate analysis showed that a high AFR-NLR score was an independent predictor of poor prognosis for overall survival ( <0.001). Additionally, in the nomogram including the AFR-NLR score, the net reclassification improvement index increased by 35.5% ( <0.001), and the integrated discrimination improvement index increased by 9.0% ( <0.001). The predictive accuracy of the established nomogram model was proved using Harrell's concordance index (0.811, 95% confidence interval: 0.765-0.856) and calibration curve. Notably, the decision analysis curve showed that the nomogram had a higher net benefit within most of the threshold probability range, indicating better clinical applicability.
The AFR-NLR score is a useful predictor of the prognosis of ESCC patients after radical resection, and the nomogram established on the basis of this score has a good prognostic value.
我们回顾性分析了白蛋白与纤维蛋白原比值(AFR)-中性粒细胞与淋巴细胞比值(NLR)评分(包括术前AFR和NLR)对食管鳞状细胞癌(ESCC)患者根治性切除术后的预后价值。
共纳入215例患者。使用受试者工作特征(ROC)曲线确定最佳临界值。根据低AFR(<12.06)和高NLR(≥1.78),将AFR-NLR评分分为2分(两种血液学异常均存在)、1分(存在一种异常)或0分(两种异常均不存在)。采用Kaplan-Meier曲线、Cox回归和预测列线图评估该评分的预后价值。
AFR-NLR评分的预后价值优于单独的AFR或NLR(<0.05)。多因素分析显示,高AFR-NLR评分是总生存预后不良的独立预测因素(<0.001)。此外,在包含AFR-NLR评分的列线图中,净重新分类改善指数增加了35.5%(<0.001),综合判别改善指数增加了9.0%(<0.001)。使用Harrell一致性指数(0.811,95%置信区间:0.765-0.856)和校准曲线证明了所建立列线图模型的预测准确性。值得注意的是,决策分析曲线显示,列线图在大多数阈值概率范围内具有更高的净效益,表明其临床适用性更好。
AFR-NLR评分是ESCC患者根治性切除术后预后的有用预测指标,基于该评分建立的列线图具有良好的预后价值。